John Krystal, MD

Dr. John Krystal is the Director of the Center for the Translational Neuroscience of Alcohol based at Yale University Department of Psychiatry. He is a leading expert in alcoholism, post-traumatic stress disorder, schizophrenia, and depression. His work links psychopharmacology, neuroimaging, molecular genetics, and computational neuroscience to study neurobiology and treatment of these disorders. He is best known for leading the discovery of the rapid antidepressant effects of ketamine in depressed patients. Currently, he is Co-Chair of the Forum on Neuroscience and Nervous System Disorders (NeuroForum) of the National Academies of Sciences, Engineering, and Medicine, and he edits the journal Biological Psychiatry.

Dr. Krystal is a member of the U.S. National Academy of Medicine and also serves in a variety of advisory and review capacities for organizations like NIAAA, NIMH, Wellcome Trust, the Broad Institute, and the U.S. Department of Veterans Affairs. Dr. Krystal previously served on the National Alcohol Abuse and Alcoholism Advisory Council (NIAAA), the Department of Defense Psychological Health Advisory Committee, the National Institute of Mental Health (NIMH) Advisory Council, and the NIMH Board of Scientific Counselors. He has led the American College of Neuropsychopharmacology and International College of Neuropsychopharmacology as president.